Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Seralutinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 93,099Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Gossamer Bio Fails Phase 3 Pulmonary Arterial Hypertension Trial
    Gossamer Bio Fails Phase 3 Pulmonary Arterial Hypertension Trial

    23 Feb 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/gossamer-bio-fails-phase-3-pulmonary-arterial-hypertension-trial-tries-thread-path-market

    FIERCE BIOTECH
    23 Feb 2026
    Share Share
    Gossamer Bio Issues Inducement Grant Per Nasdaq LR 5635(C)(4)
    Gossamer Bio Issues Inducement Grant Per Nasdaq LR 5635(C)(4)

    08 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260108468807/en/Gossamer-Bio-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635c4

    BUSINESSWIRE
    08 Jan 2026
    Share Share
    Gossamer Bio Issues Inducement Grant Per Nasdaq LR 5635(C)(4)
    Gossamer Bio Issues Inducement Grant Per Nasdaq LR 5635(C)(4)

    09 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251209606832/en/Gossamer-Bio-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635c4

    BUSINESSWIRE
    09 Dec 2025
    Share Share
    Gossamer Bio To Participate In Upcoming Investor Conferences
    Gossamer Bio To Participate In Upcoming Investor Conferences

    24 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251124688603/en/Gossamer-Bio-to-Participate-in-Upcoming-Investor-Conferences

    BUSINESSWIRE
    24 Nov 2025
    Share Share
    Gossamer Bio To Participate In Upcoming Investor Conferences
    Gossamer Bio To Participate In Upcoming Investor Conferences

    07 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251107017321/en/Gossamer-Bio-to-Participate-in-Upcoming-Investor-Conferences

    BUSINESSWIRE
    07 Nov 2025
    Share Share
    Gossamer Bio Announces Inducement Grant Under Nasdaq LR 5635(c)(4)
    Gossamer Bio Announces Inducement Grant Under Nasdaq LR 5635(c)(4)

    07 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250207717407/en

    BUSINESSWIRE
    07 Feb 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.